IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
-7.62%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$297M
AUM Growth
-$31.7M
(-9.6%)
Cap. Flow
-$15.4M
Cap. Flow
% of AUM
-5.17%
Top 10 Holdings %
Top 10 Hldgs %
47.78%
Holding
70
New
9
Increased
18
Reduced
13
Closed
5
Top Buys
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$8.41M |
| 2 |
uniQure
QURE
|
$8.23M |
| 3 |
Biogen
BIIB
|
$7.51M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$7.34M |
| 5 |
Gilead Sciences
GILD
|
$6.67M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$14.9M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$11.8M |
| 3 |
Amgen
AMGN
|
$10.2M |
| 4 |
Harmony Biosciences
HRMY
|
$8.39M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$7.93M |
Sector Composition
| 1 | Healthcare | 99.21% |
